Endpoints News 生物医药· Drew Armstrong·· 8 天前AI 评分26
百时美施贵宝调整研发领导层,专利悬崖前人事变动
Updated: Bristol Myers shakes up R&D leadership ahead of patent cliff
AI 导读
百时美施贵宝宣布研发主管 Robert Plenge 卸任,其职责由 Cristian Măzărescu 接任。此次人事调整发生在公司即将面临专利悬崖的背景下。
正文
Bristol Myers Squibb is changing up its R&D leadership, moving out research chief Robert Plenge and handing his responsibilities to Cristian Massacesi, the company’s chief …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news